DE69634412T3 - Regulierte gene und ihre verwendungen - Google Patents

Regulierte gene und ihre verwendungen Download PDF

Info

Publication number
DE69634412T3
DE69634412T3 DE69634412T DE69634412T DE69634412T3 DE 69634412 T3 DE69634412 T3 DE 69634412T3 DE 69634412 T DE69634412 T DE 69634412T DE 69634412 T DE69634412 T DE 69634412T DE 69634412 T3 DE69634412 T3 DE 69634412T3
Authority
DE
Germany
Prior art keywords
protein
fos
nucleotide molecule
figf
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634412T
Other languages
German (de)
English (en)
Other versions
DE69634412T2 (de
DE69634412D1 (de
Inventor
Salvatore Oliviero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vegenics Pty Ltd
Original Assignee
Vegenics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26307843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69634412(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9519928.7A external-priority patent/GB9519928D0/en
Priority claimed from GBGB9612368.2A external-priority patent/GB9612368D0/en
Application filed by Vegenics Pty Ltd filed Critical Vegenics Pty Ltd
Application granted granted Critical
Publication of DE69634412D1 publication Critical patent/DE69634412D1/de
Publication of DE69634412T2 publication Critical patent/DE69634412T2/de
Publication of DE69634412T3 publication Critical patent/DE69634412T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69634412T 1995-09-29 1996-09-30 Regulierte gene und ihre verwendungen Expired - Lifetime DE69634412T3 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9519928.7A GB9519928D0 (en) 1995-09-29 1995-09-29 Regulated genes and uses thereof
GB9519928 1995-09-29
GB9612368 1996-06-13
GBGB9612368.2A GB9612368D0 (en) 1996-06-13 1996-06-13 Regulated genes and uses thereof
PCT/IB1996/001113 WO1997012972A2 (en) 1995-09-29 1996-09-30 Regulated genes and uses thereof
EP96932771A EP0853668B2 (en) 1995-09-29 1996-09-30 Regulated genes and uses thereof

Publications (3)

Publication Number Publication Date
DE69634412D1 DE69634412D1 (de) 2005-04-07
DE69634412T2 DE69634412T2 (de) 2005-12-15
DE69634412T3 true DE69634412T3 (de) 2013-07-04

Family

ID=26307843

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69634412T Expired - Lifetime DE69634412T3 (de) 1995-09-29 1996-09-30 Regulierte gene und ihre verwendungen
DE69638142T Expired - Lifetime DE69638142D1 (de) 1995-09-29 1996-09-30 Regulierte Gene und ihre Verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69638142T Expired - Lifetime DE69638142D1 (de) 1995-09-29 1996-09-30 Regulierte Gene und ihre Verwendungen

Country Status (11)

Country Link
US (1) US8383788B2 (https=)
EP (2) EP1553182B1 (https=)
JP (1) JP4086315B2 (https=)
AT (2) ATE290077T1 (https=)
AU (1) AU7142996A (https=)
CA (1) CA2230957A1 (https=)
DE (2) DE69634412T3 (https=)
ES (2) ES2239338T5 (https=)
IL (1) IL123649A0 (https=)
NO (1) NO981353L (https=)
WO (1) WO1997012972A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
EP1353952B1 (en) 1994-11-14 2007-04-11 Ludwig Institute For Cancer Research Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
DE69628652T3 (de) 1995-09-08 2012-05-03 Genentech, Inc. Vegf-verwandtes protein
DE69634412T3 (de) 1995-09-29 2013-07-04 Vegenics Pty Ltd Regulierte gene und ihre verwendungen
WO1998002543A1 (fr) 1996-07-15 1998-01-22 Chugai Research Institute For Molecular Medicine, Inc. Nouveaux facteurs analogues au vegf
WO1998007832A1 (en) 1996-08-23 1998-02-26 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
AU5439998A (en) * 1996-12-06 1998-06-29 Zymogenetics Inc. Vascular endothelial growth factor
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1345247A (zh) * 1997-12-24 2002-04-17 路德维格癌症研究所 表达血管内皮生长因子d的表达载体和细胞系以及治疗黑素瘤的方法
DE19847422C1 (de) * 1998-10-14 2000-01-13 Forschungszentrum Juelich Gmbh Chinese-Hamster-Ovary-Zellen zur Produktion von Proteinen
AU764039B2 (en) 1998-12-07 2003-08-07 Zymogenetics Inc. Growth factor homolog ZVEGF3
WO2001012669A1 (en) * 1999-08-16 2001-02-22 Universita' Degli Studi Di Siena Vegf-d and angiogenic use thereof
AU3988401A (en) * 2000-02-25 2001-09-03 Ludwig Inst Cancer Res Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
WO2003006104A2 (en) * 2001-07-12 2003-01-23 Ludwig Institute For Cancer Research Lymphatic endothelial cells materials and methods
US20030113324A1 (en) * 2001-10-01 2003-06-19 Kari Alitalo Neuropilin/VEGF-C/VEGFR-3 materials and methods
US20040214766A1 (en) * 2001-10-01 2004-10-28 Kari Alitalo VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
US20040248796A1 (en) * 2003-02-04 2004-12-09 Kari Alitalo VEGF-B and PDGF modulation of stem cells
EP1635860A2 (en) * 2003-06-12 2006-03-22 Ludwig Institute For Cancer Research Use of vegf-c or vegf-d in reconstructive surgery
WO2005016963A2 (en) * 2003-06-12 2005-02-24 Ludwig Institute For Cancer Research Heparin binding veger-3 ligands
WO2005087177A2 (en) 2004-03-05 2005-09-22 Ludwig Institute For Cancer Research Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same
ITRM20050367A1 (it) * 2005-07-08 2007-01-09 Univ Siena Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.
EP1919944B1 (en) 2005-08-15 2011-03-23 Vegenics Pty Ltd Modified vegf and pdgf with improved angiogenic properties
US9073997B2 (en) * 2007-02-02 2015-07-07 Vegenics Pty Limited Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
US8571840B2 (en) * 2007-03-28 2013-10-29 Autodesk, Inc. Constraint reduction for dynamic simulation
WO2011154308A1 (en) 2010-06-08 2011-12-15 Proyecto De Biomedicina Cima, S.L. New compositions and cell therapy methods for the treatment of cirrhosis
US9492265B2 (en) 2012-01-06 2016-11-15 Emboline, Inc. Integrated embolic protection devices
PT2956476T (pt) 2013-02-18 2020-02-21 Vegenics Pty Ltd Moléculas de ligação e usos destas
EP3341397B1 (en) * 2015-08-25 2024-12-18 Histide AG Compounds for inducing tissue formation and uses thereof
IL298067A (en) 2015-08-25 2023-01-01 Histide Ag Compounds for inducing tissue formation and their uses
US10617509B2 (en) 2015-12-29 2020-04-14 Emboline, Inc. Multi-access intraprocedural embolic protection device
CN113677296B (zh) 2019-02-13 2024-12-31 艾姆伯莱恩公司 具有整合的栓塞防护装置的导管

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135983D0 (da) 1983-03-25 1983-03-25 Novo Industri As Maltogen amylaseenzymprodukt og fremgangsmade til dets fremstilling og anvendelse
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5968778A (en) 1989-01-12 1999-10-19 Jurgen Hoppe PDGF-AB, preparation process and pharmaceuticals containing them
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
JP3024311B2 (ja) 1991-10-03 2000-03-21 味の素株式会社 Ｉｌ−２受容体重鎖に結合するポリペプチド
JPH05271294A (ja) 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするｄｎａ
NZ253611A (en) 1992-07-27 1996-09-25 Pfizer Polypeptide found in the venom of the agelenopsis spider and its use as a calcium channel blocker
ES2249762T3 (es) 1994-03-08 2006-04-01 Human Genome Sciences, Inc. Factor de crecimiento del endotelio vascular 2.
US5814464A (en) 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US6645933B1 (en) 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
US6221839B1 (en) 1994-11-14 2001-04-24 Helsinki University Licensing Ltd. Oy FIt4 ligand and methods of use
JPH08185216A (ja) 1994-12-28 1996-07-16 Meidensha Corp 工具姿勢パラメータ設定方法及びロボット制御装置
US5928939A (en) 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
NZ301611A (en) 1995-03-02 2000-02-28 Amrad Operations Pty Ltd a peptide having vascular endothelial growth factor like properties, nucleic acid molecule encoding it and its use
WO1996039421A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human vascular endothelial growth factor 3
DE69634412T3 (de) 1995-09-29 2013-07-04 Vegenics Pty Ltd Regulierte gene und ihre verwendungen
WO1998002543A1 (fr) 1996-07-15 1998-01-22 Chugai Research Institute For Molecular Medicine, Inc. Nouveaux facteurs analogues au vegf
WO1998007832A1 (en) 1996-08-23 1998-02-26 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
AU5439998A (en) 1996-12-06 1998-06-29 Zymogenetics Inc. Vascular endothelial growth factor
NZ336813A (en) 1997-02-18 2000-02-28 Ludwig Inst Cancer Res Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B) DNA and uses in the promotion of growth of new blood vessels
DE69930872T8 (de) 1998-12-21 2007-05-03 Ludwig Institute For Cancer Research Antikörper gegen verkürzten vegf-d und deren verwendungen
WO2001012669A1 (en) 1999-08-16 2001-02-22 Universita' Degli Studi Di Siena Vegf-d and angiogenic use thereof
CN101998963B (zh) 2008-02-12 2014-09-24 陶氏益农公司 杀虫组合物

Also Published As

Publication number Publication date
WO1997012972A3 (en) 1997-06-12
EP1553182B1 (en) 2010-03-03
ES2239338T3 (es) 2005-09-16
DE69634412T2 (de) 2005-12-15
IL123649A0 (en) 1998-10-30
WO1997012972A2 (en) 1997-04-10
DE69638142D1 (de) 2010-04-15
ES2341864T3 (es) 2010-06-29
JP4086315B2 (ja) 2008-05-14
US20020123481A1 (en) 2002-09-05
ES2239338T5 (es) 2013-05-31
EP1553182A2 (en) 2005-07-13
EP1553182A3 (en) 2008-03-05
NO981353D0 (no) 1998-03-25
EP0853668A2 (en) 1998-07-22
JP2001501442A (ja) 2001-02-06
US8383788B2 (en) 2013-02-26
ATE459715T1 (de) 2010-03-15
EP0853668B1 (en) 2005-03-02
CA2230957A1 (en) 1997-04-10
NO981353L (no) 1998-03-25
EP0853668B2 (en) 2013-03-06
AU7142996A (en) 1997-04-28
DE69634412D1 (de) 2005-04-07
ATE290077T1 (de) 2005-03-15

Similar Documents

Publication Publication Date Title
DE69634412T3 (de) Regulierte gene und ihre verwendungen
DE69733204T3 (de) Neuartige vegf-ähnliche faktoren
EP1027440B1 (de) Inhibitor-protein des wnt-signalwegs
DE69531892T2 (de) Fibroblasten-wachstumsfaktor 10
DE69022559T2 (de) Expression des rekombinanten Tumor-Nekrosisfaktor-Bindungsproteins I (TBP-I).
DE69833649T2 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
Tamura et al. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors.
DE69824719T2 (de) Cytokinähnlicher faktor-7 aus säugetieren
DE69926764T2 (de) Methoden zur bestimmung von komponenten zur modulation des körpergewichts
DE69323131T2 (de) Rekombinierte alkalische phosphatase aus kälberdarm
DE69432901T2 (de) Expressionssystem von antikörpern bei homologischer rekombinierung in murinezellen
DE69819505T2 (de) Mit smad wechselwirkende polypeptide und verwendungen davon
DE69937570T2 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DE69332798T2 (de) Ikaros: ein regulatorisches gen bei der t-zell differenzierung
DE4425481A1 (de) Melanom-inhibierendes Protein
EP0875567A2 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE69532874T2 (de) RPDL Protein und kodierende DNS
DE10257421A1 (de) Regulatorische Elemente im 5'-Bereich des VR1-Gens
JPH06256210A (ja) 骨関連転写制御因子様タンパク質およびその製造法
DE69233155T2 (de) Insulinartigen wachstumsfaktor bindendes protein
DE69433902T2 (de) Neuartige tyrosinkinase
AT410672B (de) Nucleinsäure, die einen nervengewebe-natriumkanal kodiert
DE69836278T2 (de) Allele formen von menschlichem stat3
DE69731682T2 (de) TAB1 Protein und dafür kodierende DNA
DE69635667T2 (de) Biologisch aktive liganden der eph familie

Legal Events

Date Code Title Description
8363 Opposition against the patent